Gail Book Photo Soft web02
  Gail Bebee
Canada's Independent Voice on Personal Finance

Personal Finance Speaker and Author

  • All the investing basics for Canadians from a savvy financial industry outsider
  • Get the knowledge you need to cut through financial industry hype and profitably invest your hard-earned money
  • Benefit from the author’s years of hard-knocks investing experience







  Buy Now!  

and receive our free Report on Tax Free Savings Accounts!


Learn how to:

  • Build a successful investment  portfolio whether you have $100 or $100,000
  • Keep investing costs down
  • Pick the best stocks, bonds,  mutual funds and exchange-traded funds
  • Choose the right financial  advisor for you
  • Avoid common investing mistakes
  • Reduce the tax you pay on investing profits
  • Plan your finances for retirement regardless of age
  • And much more!


Latest market News


  • Retailers; auto parts retailer AAP slipped after reports lower-than-expected Q3 gross margin of 43.9% compared with estimated 44.4%, hurt by an increase in coupon redemptions while cuts 2019 comp store sales growth forecast to a range of 1.0%-1.5% from 1.0%-2.0%; OSTK reported a miss on the top and bottom line as revenue fell 21% in Q3 and gross profit was down 20% with an EBITDA loss of $18M was generated vs. -$14.2M consensus; gun makers AOBC and RGR shares slipped after U.S. Supreme Court lets Sandy Hook families sue
  • Consumer Staples; BREW shares surge following its buyout by BUD for remaining stake it doesn’t own, as the offer represents a premium of 125% to BREW's Monday close/BREW holders to get $16.50 per share in cash https://on.mktw.net/2q7IEs1 ; DF initiated voluntary Chapter 11 reorganization proceedings in the Southern District of Texas; GO posted better- than-expected 3Q profitability and a conservative 4Q guide; KR was upgraded to buy at Deutsche Bank; TSN reported both an earnings and quarterly sales miss after chicken revenue came in lower than anticipated due chiefly to a 2.4% drop in prices, but shares rallied
  • Housing & Building Products; homebuilder DHI topped estimates for Q4 profit and forecast 2020 home sales above estimates as expects home sales for 2020 to be between 60,000 and 61,000 homes, compared with analysts' estimates of 59,737 homes



  • Bank movers/advisors; LTS to be acquired by wealth management firm Advisor Group in an all-cash deal valued at $1.3 bln, the companies said on Monday, after the bell; Advisor's offer of $3.50/share represents a premium of ~25% to LTS' Monday close https://yhoo.it/2qP2xE8 
  • Insurance, Consumer finance and lending; WU was downgraded to hold at Guggenheim on balanced risk/reward after shares reached our prior $28 PT on 11/7; ARGO shares rose after KBW upgraded to outperform as estimates Argo will take a $53M reserve charge in Q4 to deal with leftover international deficiency gap and sees this restoring "balance sheet confidence."
  • Asset managers; companies out with month assets under management (AUM) data) as APAM AUM as of October 31 totaled $114.5B; CNS prelim AUM $72B as of October 31, an increase of $1.1B from assets under management at September 30; BEN prelim AUM of $693.1 billion at October 31, 2019, compared to $692.6 billion at September 30, 2019; IVZ prelim AUM of $1,195.2 billion, an increase of 0.9% versus previous month-end; LM prelim AUM of $791.0 billion as of Oct 31, 2019; LAZ prelim AUM approximately $235.8B as of October 31; TROW prelim AUM was $1.15 trillion as of October 31, 2019; WDR preliminary AUM $68.9B as of October 31 - compared to $68.8B on September 30.



  • Pharma movers; LLY said Taltz met the primary and all major secondary endpoints in the COAST-X placebo-controlled Phase 3 study in non-radiographic axial spondyloarthritis; TEVA was upgraded to neutral at JPMorgan noting near-to-mid-term fundamentals are stabilizing, while firm downgraded AMRX to underweight as remain fairly bearish on the longer-term setup for the company; KDMN jumps after a pivotal Phase 2 study evaluating its lead candidate KD025 in patients with chronic graft-vs-host disease (cGvHD) who had received at least two prior lines of therapy met the primary endpoint at the interim analysis; AMRN rises after briefing docs were made available this morning for 11/14's adcom which will discuss the potential approval for Vascepa's sNDA to include CV risk reduction based on the REDUCE-IT study results
  • Biotech movers; SLDB shares plunge after the FDA places its Phase I/II study of SGT-001, a gene transfer candidate for Duchenne muscular dystrophy, on clinical hold after one dosed patient experienced a serious adverse event deemed related to the study drug; RETA announced that the Phase III portion of the CARDINAL study of bardoxolone in patients with chronic kidney disease caused by Alport syndrome met its primary and key secondary endpoints; CRSP was upgraded to outperform wit $65 tgt at Oppenheimer while EDIT rises on earnings
  • Medical equipment, devices and services; ICUI shares jumped after a beat on the top and bottom line last night as sales and EBITDA were generally in line with expectations and it reiterated 2019 guidance; DPLO shares plunged after Q3 revenue was down 5% to $1,301M while loss/share was ($2.35) compared to break-even a year ago and issued sharply lower downside EPS loss guidance with net loss: ($368M - 361M) from ($201M - 191M); APYX rises as raises FY19 revenue view to $27.4M-$27.9M from $26.5M-$27.5M and sees FY19 adjusted EBITDA ($16.9M)-($16.4M).


Industrials & Materials

  • Industrial & Materials; ROK shares rise after Q4 profit beat expectations on higher organic sales and issued full-year 2020 profit guidance above estimates (guides year EPS $8.70-$9.10 vs. est. $8.52); BA shares slipped a day after being the top % gainer for the Dow yesterday after the company said it may be able to resume deliveries of the grounded 737 Max as soon as next month depending on the successful completion of a series of milestones with U.S. regulators; VRS rises after posting unexpected profit and announces Mill sales for $400M; GE, HON, ARNC, ETN, GWW, TDG, ROK, CAT among industrial names touching 52-week highs today
  • Transports; CSX was downgraded to hold from buy at Deutsche Bank; JBLU this morning reported Oct capacity up 6.7%, load factor 82.5% and traffic rose 6.2% and reiterated Q4 RASM of down .5 to -3.5%


Technology, Media & Telecom

  • Semiconductors; KEM to be acquired by Taiwan's Yageo Corp. for $1.8 billion in cash, with KEM shareholders to receive $27.20 a share https://on.mktw.net/33CPqo9 ; IIVI shares slide after a mixed Q1 with upside revenue and an earnings miss and forecasts a downside Q2 with revenue of $590-630M and $0.20-0.50 EPS and margins fell to 36.2% from 39.4% last quarter; SWKS among the big names reporting earnings tonight; AMAT tgt raised to $65 from $55 at Cowen named new top pick and says would be buying into the print
  • Software movers; Goldman Sach’s initiates software security sector with buys on PANW, FTNT, VRNT a sell on SCWX as awaits a recovery and neutral on CHKP, FEYE; Goldman also upgraded CRWD to neutral from sell after shares fell 23% since its downgrade; BOX was downgraded to market perform at JMP Securities ahead of Q3 results this month as expects challenges; ADSK rises on positive Baird comments saying they like risk/reward over next month as a better-than-feared 3Q report and notable Autodesk events could provide catalysts for stock; TWLO shares fell on reports WhatsApp (largest customer) said to be scaling back usage
  • Media & Telecom movers; VOD raised its FY20 adjusted earnings guidance, as now sees year Ebitda between 14.8B-15B euros above prior 13.8B-14.2B euros; FLNT shares drop after company reports an unexpected 3Q loss and also cuts its FY19 guidance to $265M-$267M from $277M-$285M; Dow component DIS rises as its Disney+ streaming service goes live today, but company acknowledged technical issues due to the overwhelming response; CBS said Q3 profit fell 35% as the media co ramped up spending, but results were mixed with EPS beat and sales just missing
  • Services, Hardware & Component news; INFN posted in-line quarterly EPS of 17c on a slight miss on revenue; DXC rises after announces plans to explore strategic options for three of its business segments, reversing previous declines after Q2 results missed consensus projections

Policies and Conditions